European Pharmaceutical Review
JULY 18, 2023
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97
Express Pharma
NOVEMBER 5, 2024
The global enoxaparin market was valued at US $3,315 million in 2023 and is projected to reach US $5,415 million by 2030, growing at a rate of 7.1 per cent from 2024 to 2030. PIC/S comprises 52 active member states and fosters cooperation between regulatory authorities and the pharmaceutical industry to promote GMP.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JUNE 10, 2024
The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. The company hopes to produce this number tenfold by the end of 2030.
Express Pharma
NOVEMBER 13, 2024
Renowned as a comprehensive, one-stop destination for innovative, cost-effective solutions, the expo will be showcasing the pharmaceutical industry’s modernisation, innovation, and sustainability. India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030.
Express Pharma
NOVEMBER 18, 2024
The event will showcase developments in pharmaceutical modernisation, innovation, and sustainability. India’s pharmaceutical industry is projected to reach $65 billion by 2024 and is expected to double to $130 billion by 2030.
European Pharmaceutical Review
OCTOBER 31, 2022
According to the Intergovernmental Panel on Climate Change (IPCC), emissions must achieve reduction of 43 percent by 2030. Sustainable energy strategies for pharmaceutical manufacturers… The post Biopharma successful in achieving climate-related goals, report finds appeared first on European Pharmaceutical Review.
Express Pharma
NOVEMBER 29, 2023
Driven by this momentum, I am confident in reaching the 130 billion mark by 2030, advocating for a consistent 10 per cent growth in both domestic and export markets. Despite challenges in CIS countries, the global reception of Indian pharma remains positive. The domestic market has exhibited impressive growth, exceeding 10 per cent.
Expert insights. Personalized for you.
98 
Let's personalize your content